Skip to content

Clinical trials

Phase 3 Breast Neoplasms trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Phase 3 Country / region: United Kingdom Clear all

209 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20018
20021
20038
20048
20057
200610
20079
200810
200910
20106
20116
20127
20137
20146
20155
20163
20177
20188
20196
20204
202111
20229
202310
20243
202510

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed115
Active, not recruiting36
Unknown status27
Recruiting17
Terminated13
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche29
Novartis Pharmaceuticals20
AstraZeneca18
Pfizer10
Eli Lilly and Company7
Institute of Cancer Research, United Kingdom7
Scottish Cancer Therapy Network7
European Organisation for Research and Treatment of Cancer - EORTC6
Merck Sharp & Dohme LLC5
Sanofi5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms209
Neoplasm Metastasis26
Neoplasms11
Breast Diseases6
Breast Neoplasms, Male6
Inflammatory Breast Neoplasms5
Neoplasms by Site5
Triple Negative Breast Neoplasms5
Brain Neoplasms4
Ovarian Neoplasms4

Trials

Showing 1 to 25 of 209. Each trial links to its page on Pharma Observatory.

109 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.